in silico bio-evolutio - novel AI paradigm for molecular biology
The success of phage therapies relies on correctly matching a therapeutic phage to bacterial strain. However calibration of therapy recipe may last for years. Presented solution enable to accelerate this by in silico simulations o...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PID2019-106960GB-I00
HACIA LA INTELIGENCIA ARTIFICIAL IN VIVO: PROGRAMACION DE FA...
87K€
Cerrado
PLEC2023-010243
Herramientas diagnósticas, pronósticas y terapéuticas
539K€
Cerrado
AI-2 Prodrugs
Development of new AI-2 prodrugs and chemical probes to stud...
157K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The success of phage therapies relies on correctly matching a therapeutic phage to bacterial strain. However calibration of therapy recipe may last for years. Presented solution enable to accelerate this by in silico simulations on AI platform for in vitro. It is able to find optimal phage that meets the phenotype imposed by the researcher, especially:
-predict given phage effectiveness against a specific bacteria strain,
-indicate mutations that increase phage effectiveness,
-generate explanations for predictions.
Currently, this process is performed by wet-lab employees (in vitro).
Replacing it with an in silico process will reduce the number 90 out of 100 experiments, significantly accelerating the process and improving phage therapy quality. At the same time, it’s the basis for modern probiotics (for microbiome modulation). At the same time, it will enable dynamically generate personalized therapies for specific patients. It is a novel endeavor in the area of molecular biology.